Your browser doesn't support javascript.
loading
TNF blockade uncouples toxicity from antitumor efficacy induced with CD40 chemoimmunotherapy.
Stone, Meredith L; Lee, Jesse; Herrera, Veronica M; Graham, Kathleen; Lee, Jae W; Huffman, Austin; Coho, Heather; Tooker, Evan; Myers, Max I; Giannone, Michael; Li, Yan; Buckingham, Thomas H; Long, Kristen B; Beatty, Gregory L.
Afiliación
  • Stone ML; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Lee J; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Herrera VM; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Graham K; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Lee JW; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Huffman A; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Coho H; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Tooker E; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Myers MI; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Giannone M; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Li Y; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Buckingham TH; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Long KB; Department of Biology, Mansfield University, Mansfield, Pennsylvania, USA.
  • Beatty GL; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
JCI Insight ; 6(14)2021 07 22.
Article en En | MEDLINE | ID: mdl-34101617
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Factor de Necrosis Tumoral alfa / Antígenos CD40 / Carcinoma Ductal Pancreático / Enfermedad Hepática Inducida por Sustancias y Drogas / Anticuerpos Monoclonales Humanizados Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: JCI Insight Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Factor de Necrosis Tumoral alfa / Antígenos CD40 / Carcinoma Ductal Pancreático / Enfermedad Hepática Inducida por Sustancias y Drogas / Anticuerpos Monoclonales Humanizados Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: JCI Insight Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos